UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 244

Sortiert nach

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

Brain (London, England : 1878), 2019-07, Vol.142 (7), p.1894-1904

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

BMC neurology, 2019-08, Vol.19 (1), p.191-191, Article 191

2019

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.328-337

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

Current medical research and opinion, 2012-03, Vol.28 (3), p.315-323

2012

Link zum Volltext

Verfügbarkeit prüfen

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

BMC psychiatry, 2014-01, Vol.14 (1), p.7-7, Article 7

2014

Link zum Volltext

Verfügbarkeit prüfen

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia

Alzheimer's & dementia : translational research & clinical interventions, 2018, Vol.4 (1), p.652-660

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

Current medical research and opinion, 2013-11, Vol.29 (11), p.1533-1537

2013

Link zum Volltext

Verfügbarkeit prüfen

112-GHz, 157-GHz, and 180-GHz InP HEMT traveling-wave amplifiers

IEEE transactions on microwave theory and techniques, 1998-12, Vol.46 (12), p.2553-2559

1998

Link zum Volltext
IEEE_Xplore

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression

The journal of clinical psychiatry, 2006-05, Vol.67 (5), p.798

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Neuroimaging Modalities for the Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia

The American journal of geriatric psychiatry, 2013-03, Vol.21 (3), p.S137-S137

2013

Link zum Volltext

Verfügbarkeit prüfen

Neuroimaging Results and A4 in the Context of the LEARN Study

Alzheimer's & dementia, 2023-12, Vol.19 (S24)

2023

Link zum Volltext

Verfügbarkeit prüfen

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians

Patient preference and adherence, 2011-01, Vol.5 (default), p.547-554

2011

Link zum Volltext

Verfügbarkeit prüfen

Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials

Alzheimer's & dementia, 2023-12, Vol.19 (S14), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Architecture, design, and test of continuous-time tunable intermediate-frequency bandpass delta-sigma modulators

IEEE journal of solid-state circuits, 2001-01, Vol.36 (1), p.5-13

2001

Link zum Volltext
IEEE_Xplore

EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P37-P38

2017

Link zum Volltext

Verfügbarkeit prüfen

EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P605-P605

2017

Link zum Volltext

Verfügbarkeit prüfen

PET BIOMARKERS IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1452-P1452

2017

Link zum Volltext

Verfügbarkeit prüfen

DELAYED-START ANALYSES IN THE PHASE 3 SOLANEZUMAB EXPEDITION3 STUDY IN MILD ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1260-P1260

2017

Link zum Volltext

Verfügbarkeit prüfen

SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER’S DISEASE DEMENTIA

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P251-P252

2017

Link zum Volltext

Verfügbarkeit prüfen

SOLANEZUMAB CENTRAL TARGET ENGAGEMENT AND PHARMACODYNAMIC ACTIVITY IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD: COMPARISON TO EXPEDITION/EXPEDITION 2

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P254-P255

2017

Link zum Volltext

Verfügbarkeit prüfen

Active and nonlinear wave propagation devices in ultrafast electronics and optoelectronics

Proceedings of the IEEE, 1994-07, Vol.82 (7), p.1037-1059

1994

Link zum Volltext
IEEE_Xplore

40-W CW broad-band spatial power combiner using dense finline arrays

IEEE transactions on microwave theory and techniques, 1999-07, Vol.47 (7), p.1070-1076

1999

Link zum Volltext
IEEE_Xplore

State-variable-based transient analysis using convolution

IEEE transactions on microwave theory and techniques, 1999-06, Vol.47 (6), p.882-889

1999

Link zum Volltext
IEEE_Xplore

Sharp Alfvénic Impulses in the Near-Sun Solar Wind

The Astrophysical journal. Supplement series, 2020-02, Vol.246 (2), p.45

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Cell host & microbe, 2020-09, Vol.28 (3), p.475-485.e5

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 244

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(212)

Publikationsform

Artikel
(238)
Reviews
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(140)
Humans
(139)
Female
(71)
Male
(67)
Adult
(52)
Biological And Medical Sciences
(52)
Middle Aged
(50)
Genome-Wide Association Study
(44)
Aged
(43)
Medical Sciences
(43)
Risk Factors
(43)
Genetics & Heredity
(42)
Genetics
(35)
Genetic Predisposition To Disease
(34)
Physical Sciences
(34)
Fundamental And Applied Biological Sciences. Psychology
(30)
Polymorphism, Single Nucleotide
(30)
Genetic Aspects
(27)
Medicin Och Hälsovetenskap
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

112-GHz, 157-GHz, and 180-GHz InP HEMT traveling-wave amplifiers

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression

Comparison of Neuroimaging Modalities for the Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia

Neuroimaging Results and A4 in the Context of the LEARN Study

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians

Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials

Architecture, design, and test of continuous-time tunable intermediate-frequency bandpass delta-sigma modulators

EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE

EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE

PET BIOMARKERS IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD

DELAYED-START ANALYSES IN THE PHASE 3 SOLANEZUMAB EXPEDITION3 STUDY IN MILD ALZHEIMER’S DISEASE

SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER’S DISEASE DEMENTIA

SOLANEZUMAB CENTRAL TARGET ENGAGEMENT AND PHARMACODYNAMIC ACTIVITY IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD: COMPARISON TO EXPEDITION/EXPEDITION 2

Active and nonlinear wave propagation devices in ultrafast electronics and optoelectronics

40-W CW broad-band spatial power combiner using dense finline arrays

State-variable-based transient analysis using convolution

Sharp Alfvénic Impulses in the Near-Sun Solar Wind

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Aktive Filter

Suchergebnisse filtern